BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
32
Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.EBI
Merck
8
Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?EBI
University of South Australia
19
Discovery of potent and selective CDK8 inhibitors through FBDD approach.EBI
Roche Innovation Center Shanghai
2
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML.EBI
Chinese Academy of Sciences
483
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitorsBDB
Array Biopharma
288
PCSK9 inhibitors and methods of use thereofBDB
AstraZeneca
243
Triazolopyrimidine compounds and uses thereofBDB
Novartis
243
Piperidine derivatives as inhibitors of ubiquitin specific protease 7BDB
Almac Discovery
55
Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methodsBDB
Indiana University Research and Technology